MedPath

Evaluation of the Effectiveness of iPACK and Adductor Canal Blocks on Patients Undergoing Arthroscopic Knee Surgery

Not Applicable
Not yet recruiting
Conditions
Patients Undergoing Arthroscopic Knee Surgery
Registration Number
NCT07002580
Lead Sponsor
Sakarya University
Brief Summary

Arthroscopic knee surgery is one of the most commonly performed procedures in orthopedic surgery. More than 50% of patients experience moderate to severe pain after the operation. Inadequate postoperative pain control and poor recovery quality can negatively impact physiotherapy protocols, prolong hospital stays, and consequently lead to cognitive dysfunction, systemic infections, and increased healthcare costs.

Therefore, reducing postoperative pain and improving recovery quality are of great importance. In our clinic, a variety of analgesic techniques are routinely employed as part of a multimodal analgesia approach for patients undergoing arthroscopic knee surgery. One of these techniques is the simultaneous application of the IPACK block and the adductor canal block.

In this study, we aim to evaluate the effectiveness of these blocks on postoperative recovery quality in patients undergoing arthroscopic knee surgery.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
64
Inclusion Criteria
  • Patients aged between 18 and 50 years,
  • Scheduled for arthroscopic knee surgery under spinal anesthesia due to knee pathology
  • Patients classified as ASA physical status I-II-III according to the American Society of Anesthesiologists risk classification
Exclusion Criteria
  • Coagulopathy
  • ASA IV-V patients
  • Uncooperable patients
  • Patients who refuses to participate in study
  • Patients who takes chronic pain treatments

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Quality of Recovery24 hours.

Quality of Recovery of the patients will be assessed with QoR-15 questionnaire. Its scoring will range between 0 and 150 points.

Secondary Outcome Measures
NameTimeMethod
Analgesic Consumption24 hours.

The total analgesic consumption of patients according to the patient controlled analgesia device which measures the opioid consumption for 24 hours.

Trial Locations

Locations (1)

Sakarya University Training and Research Hospital

🇹🇷

Sakarya, Turkey

© Copyright 2025. All Rights Reserved by MedPath